Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors
Abstract
Research context
OpenAlex topics: Cancer Immunotherapy and Biomarkers · Immune cells in cancer · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Grouf of BioNanoSciences ‐ Drug Delivery and Immunoengineering, Research Institute for Medicines (iMed.ULisboa), Department of Pharmacy, Pharmacology and Health Technologies Faculty of Pharmacy Universidade de Lisboa Lisbon 1649‐003 Portugal
Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Lisbon Academic Medical Center Universidade de Lisboa Lisbon 1649‐028 Portugal
Department of Chemistry, Faculty of Chemistry and Food Chemistry, School of Science Technische Universität Dresden 01062 Dresden Germany
Group of Biomedical Research in Digestive Tract Tumors CIBBIM‐Nanomedicine Vall d'Hebron Research Institute (VHIR) Universitat Autònoma de Barcelona (UAB) Barcelona 08035 Spain
Group of Molecular Oncology Lleida Biomedical Research Institute (IRBLleida) Lleida 25198 Spain
Centro de Química Estrutural Departamento de Química e Bioquímica Institute of Molecular Sciences Faculty of Sciences Universidade de Lisboa Lisbon 1749‐016 Portugal
Department of Physiology and Pharmacology Faculty of Medicine Sagol School of Neuroscience Tel Aviv University Tel Aviv 69978 Israel
Funding
Israel Science Foundation · Melanoma Research Alliance